Pre-exercise blood glucose affects glycemic variation of aerobic exercise in patients with type 2 diabetes treated with Continuous Subcutaneous Insulin Infusion
Diabetes Research and Clinical Practice May 10, 2018
Hu Y, et al. - Researchers explored how certain factors influenced the efficacy and safety of aerobic exercise in patients with type 2 diabetes (T2D) treated with Continuous Subcutaneous Insulin Infusion (CSII). An aggregate of 267 patients with T2D, treated with CSII, were studied. Researchers reported that pre-exercise blood glucose (PEBG) was positively associated with aerobic exercise efficacy. When the PEBG >16.7 mmol/L, aerobic exercise will not worsen hyperglycemia. Better than other periods of the day, post-dinner exercise decreases blood glucose.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries